prof. MUDr. Jiří Mayer, CSc.

Department head, Department of Internal Medicine, Hematology and Oncology

correspondence Address:
Jihlavská 340/20, 625 00 Brno

phone:	+420 532 23 3643, 3603
e‑mail:

social and academic networks:

Basic information

Supervision

Qualifications

Publications

Type

Total number of publications: 1630

2024

Asciminib in Newly Diagnosed Chronic Myeloid Leukemia

HOCHHAUS Andreas WANG Jianxiang KIM Dong-Wook KIM Dennis Dong Hwan MAYER Jiří GOH Yeow-Tee PHILIPP le Coutre TAKAHASHI Naoto KIM Inho ETIENNE Gabriel ANDORSKY David ISSA Ghayas C LARSON Richard A BOMBACI Felice KAPOOR Shruti MCCULLOCH Tracey MALEK Kamel YAU Lillian IFRAH Sophie HOCH Matthias CORTES Jorge E HUGHES Timothy P

Article in Periodical

New England Journal of Medicine, year: 2024, DOI
Clinical efficacy and safety of first-line nilotinib or imatinib therapy in patients with chronic myeloid leukemia-Nationwide real life data

BELOHLAVKOVA Petra ŽÁČKOVÁ Daniela KLAMOVA Hana FABER Edgar KARAS Michal STEJSKAL Lukas CMUNT Eduard CERNA Olga JEŽÍŠKOVÁ Ivana MACHOVA POLAKOVA Katerina ZAK Pavel JURKOVÁ Tereza CHRÁPAVÁ Marika MAYER Jiří

Article in Periodical

Cancer Medicine, year: 2024, volume: 13, edition: 17, DOI
De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors

HORŇÁK Tomáš MAYER Jiří ČIČÁTKOVÁ Petra SEMERÁD Lukáš KVETKOVÁ Anežka KLAMOVA Hana FABER Edgar BELOHLAVKOVA Petra KARAS Michal STEJSKAL Lukas CMUNT Eduard CERNA Olga SRBOVA Dana ZIZKOVA Hana VRABLOVA Lucia SKOUMALOVA Ivana VOGLOVA Jaroslava JURKOVA Tereza CHRAPAVA Marika JURČEK Tomáš JEŽÍŠKOVÁ Ivana JAROŠOVÁ Marie MACHOVA POLAKOVA Katerina PAPAJIK Tomas ZAK Pavel JINDRA Pavel ŽÁČKOVÁ Daniela

Article in Periodical

American Journal of Hematology, year: 2024, volume: 99, edition: 4, DOI
European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission

MAHON Francois-Xavier PFIRRMANN Markus DULUCQ Stephanie HOCHHAUS Andreas PANAYIOTIDIS Panayiotis ALMEIDA Antonio MAYER Jiří HJORTH-HANSEN Henrik JANSSEN Jeroen J W M MUSTJOKI Satu MARTINEZ-LOPEZ Joaquin VESTERGAARD Hanne EHRENCRONA Hans POLAKOVA Katerina Machova OLSSON-STROEMBERG Ulla OSSENKOPPELE Gert BERGER Marc G ETIENNE Gabriel DENGLER Jolanta BRUEMMENDORF Tim H BURCHERT Andreas REA Delphine ROUSSELOT Philippe NICOLINI Franck E HOFMANN Wolf-Karsten RICHTER Johan SAUSSELE Susanne

Article in Periodical

Journal of clinical oncology, year: 2024, volume: 42, edition: 16, DOI
Expression of the immune checkpoint inhibitors on gamma-delta T cells in chronic myeloid leukemia patients during TKI therapy

KNIGHT Andrea PISKÁČEK Martin TOMANDLOVÁ Marie SLAMEČKOVÁ Tereza PROCHÁZKOVÁ Jiřina ŽÁČKOVÁ Daniela MAYER Jiří

Appeared in Conference without Proceedings

Year: 2024, type: Appeared in Conference without Proceedings
FoxO1/Rictor axis induces a non-genetic adaptation to Ibrutinib via Akt activation in chronic lymphocytic leukemia

ONDRIŠOVÁ Laura ŠEDA Václav HLAVÁČ Kryštof PAVELKOVÁ Petra HOFERKOVÁ Eva CHIODIN Giorgia KOŠŤÁLOVÁ Lenka MLADONICKÁ PAVLASOVÁ Gabriela FILIP Daniel VEČEŘA Josef FARIA ZENI Pedro OPPELT Jan KAHOUNOVÁ Zuzana VICHOVA Rachel SOUČEK Karel PANOVSKÁ Anna PLEVOVÁ Karla POSPÍŠILOVÁ Šárka ŠIMKOVIČ Martin VRBACKÝ Filip LYSÁK Daniel FERNANDES Stacey M. DAVIDS M.S. MAIQUES-DIAZ Alba CHARALAMPOPOULOU Stella MARTIN-SUBERO Jose I. BROWN Jenifer R. DOUBEK Michael MAYER Jiří MRÁZ Marek

Article in Periodical

The Journal of Clinical Investigation, year: 2024, DOI
Fungal infection frequency in newly diagnosed acute myeloid leukaemia patients treated with venetoclax plus azacitidine with or without antifungal prophylaxis

WEINBERGEROVÁ Barbora MAYER Jiří KABUT Tomas SPERR Wolfgang R STEVKOVA Jana JONASOVA Anna CERNAN Martin HERNDLHOFER Susanne ORAVCOVA Iveta SRAMEK Jiri NOVAK Jan ŠTĚPÁNOVÁ Radka SZOTKOWSKI Tomas DRGONA Lubos ZAK Pavel VALENT Peter

Article in Periodical

British journal of haematology, year: 2024, DOI
Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial

EFFICACE Fabio MAHON Francois-Xavier RICHTER Johan PICIOCCHI Alfonso CIPRIANI Marta NICOLINI Franck E MAYER Jiří ŽÁČKOVÁ Daniela JANSSEN Jeroen J W M PANAYIOTIDIS Panayiotis VESTERGAARD Hanne KOSKENVESA Perttu ALMEIDA Antonio HJORTH-HANSEN Henrik MARTINEZ-LOPEZ Joaquin OLSSON-STROMBERG Ulla HOCHHAUS Andreas BERGER Marc G ETIENNE Gabriel KLAMOVA Hana FABER Edgar ROUSSELOT Philippe PFIRRMANN Markus SAUSSELE Susanne

Article in Periodical

Leukemia, year: 2024, volume: 38, edition: 8, DOI
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis

OH Stephen T VERSTOVSEK Srdan GUPTA Vikas PLATZBECKER Uwe DEVOS Timothy KILADJIAN Jean-Jacques MCLORNAN Donal P PERKINS Andrew FOX Maria Laura MCMULLIN Mary Frances MEAD Adam J EGYED Miklos MAYER Jiří SACHA Tomasz KAWASHIMA Jun HUANG Mei STROUSE Bryan MESA Ruben

Article in Periodical

eJHaem, year: 2024, volume: 5, edition: 1, DOI
Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience

SOBAS Marta KNOPINSKA-POSLUSZNY Wanda PIATKOWSKA-JAKUBAS Beata GARCIA-ALVAREZ Flor DIEZ Maria Elena Amutio CABALLERO Mar MARTINEZ-CUADRON David AGUIAR Eliana GONZALEZ-CAMPOS Jose GARRIDO Ana ALGARRA Lorenzo SALAMERO Olga JAVIER de la Serna SAYAS Maria Jose PEREZ-ENCINAS Manuel Mateo VIVES Susana VIDRIALES Belen LABRADOR Jorge PRADO Ana Ines CELEBRIN Lucia MAYER Jiří BRIOSO Joana ALMUDENA de Laiglesia BERGUA Juan Miguel AMIGO Maria Luz RODRIGUEZ-MEDINA Carlos POLO Marta PLUTA Agnieszka CICHOCKA Edyta SKARUPSKI Marek SANZ Miguel A WIERZBOWSKA Agnieszka MONTESINOS Pau

Article in Periodical

Annals of hematology, year: 2024, volume: 103, edition: 2, DOI

Projects

Teaching